---
input_text: Gluten Degrading Enzymes for Treatment of Celiac Disease. Celiac disease
  (CeD) affects about 1% of most world populations. It presents a wide spectrum of
  clinical manifestations, ranging from minor symptoms to mild or severe malabsorption,
  and it may be associated with a wide variety of autoimmune diseases. CeD is triggered
  and maintained by the ingestion of gluten proteins from wheat and related grains.
  Gluten peptides that resist gastrointestinal digestion are antigenically presented
  to gluten specific T cells in the intestinal mucosa via HLA-DQ2 or HLA-DQ8, the
  necessary genetic predisposition for CeD. To date, there is no effective or approved
  treatment for CeD other than a strict adherence to a gluten-free diet, which is
  difficult to maintain in professional or social environments. Moreover, many patients
  with CeD have active disease despite diet adherence due to a high sensitivity to
  traces of gluten. Therefore, safe pharmacological treatments that complement the
  gluten-free diet are urgently needed. Oral enzyme therapy, employing gluten-degrading
  enzymes, is a promising therapeutic approach. A prerequisite is that such enzymes
  are active under gastro-duodenal conditions, quickly neutralize the T cell activating
  gluten peptides and are safe for human consumption. Several enzymes including prolyl
  endopeptidases, cysteine proteases and subtilisins can cleave the human digestion-resistant
  gluten peptides in vitro and in vivo. Examples are several prolyl endopeptidases
  from bacterial sources, subtilisins from Rothia bacteria that are natural oral colonizers
  and synthetic enzymes with optimized gluten-degrading activities. Without exception,
  these enzymes must cleave the otherwise unusual glutamine and proline-rich domains
  characteristic of antigenic gluten peptides. Moreover, they should be stable and
  active in both the acidic environment of the stomach and under near neutral pH in
  the duodenum. This review focuses on those enzymes that have been characterized
  and evaluated for the treatment of CeD, discussing their origin and activities,
  their clinical evaluation and challenges for therapeutic application. Novel developments
  include strategies like enteric coating and genetic modification to increase enzyme
  stability in the digestive tract.
raw_completion_output: |-
  primary_disease: Celiac disease (CeD)

  medical_actions: strict adherence to a gluten-free diet; oral enzyme therapy

  symptoms: minor symptoms; mild or severe malabsorption

  chemicals: gluten proteins; prolyl endopeptidases; cysteine proteases; subtilisins

  action_annotation_relationships: strict adherence to a gluten-free diet PREVENTS minor symptoms IN Celiac disease (CeD); strict adherence to a gluten-free diet PREVENTS mild or severe malabsorption IN Celiac disease (CeD); oral enzyme therapy (with prolyl endopeptidases) TREATS minor symptoms IN Celiac disease (CeD); oral enzyme therapy (with cysteine proteases) TREATS mild or severe malabsorption IN Celiac disease (CeD); oral enzyme therapy (with subtilisins) TREATS minor symptoms IN Celiac disease (CeD)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  oral enzyme therapy (with subtilisins) TREATS minor symptoms IN Celiac disease (CeD)

  ===

extracted_object:
  primary_disease: MONDO:0009032
  medical_actions:
    - strict adherence to a gluten-free diet
    - oral enzyme therapy
  symptoms:
    - minor symptoms
    - mild or severe malabsorption
  chemicals:
    - gluten proteins
    - prolyl endopeptidases
    - cysteine proteases
    - subtilisins
  action_annotation_relationships:
    - subject: strict adherence
      predicate: PREVENTS
      object: symptoms
      qualifier: MONDO:0009032
      object_qualifier: minor
      subject_extension: gluten-free diet
      object_extension: minor
    - subject: <strict adherence>
      predicate: <PREVENTS>
      object: <malabsorption>
      qualifier: <Celiac disease>
      subject_qualifier: <>
      object_qualifier: <mild or severe>
      subject_extension: <gluten-free diet>
      object_extension: <mild or severe>
    - subject: oral enzyme therapy
      predicate: TREATS
      object: minor symptoms
      qualifier: MONDO:0009032
      subject_qualifier: with prolyl endopeptidases
      subject_extension: prolyl endopeptidases
    - subject: oral enzyme therapy
      predicate: TREATS
      object: HP:0002024
      qualifier: MONDO:0009032
      subject_qualifier: with cysteine proteases
      object_qualifier: mild or severe
      subject_extension: cysteine proteases
      object_extension: mild or severe
    - subject: oral enzyme therapy
      predicate: TREATS
      object: minor symptoms
      qualifier: MONDO:0009032
      subject_qualifier: with subtilisins
      subject_extension: subtilisins
named_entities:
  - id: MONDO:0005130
    label: Celiac Disease
  - id: HP:0011473
    label: villous atrophy
  - id: MAXO:0000088
    label: diet
  - id: HP:0002014
    label: diarrhea
  - id: HP:0001903
    label: anemia
  - id: HP:0000939
    label: osteoporosis
  - id: HP:0002608
    label: Celiac Disease
  - id: MAXO:0010200
    label: Abdominal ultrasonography
  - id: HP:0003270
    label: Abdominal distension
  - id: HP:0002748
    label: Rickets
  - id: HP:0002576
    label: intussusception
  - id: CHEBI:72716
    label: TG2 inhibitors
  - id: MAXO:0000130
    label: endoscopy
  - id: MONDO:0016063
    label: Celiac disease (CD)
  - id: CHEBI:73291
    label: Anti-deamidated gliadin peptides (DGP)
  - id: HP:0011107
    label: Aphthous stomatitis
  - id: HP:0002019
    label: Constipation
  - id: HP:0002020
    label: Gastroesophageal reflux disease
  - id: CHEBI:18163
    label: GD1a
  - id: CHEBI:28175
    label: GD1b
  - id: CHEBI:28424
    label: GD3
  - id: CHEBI:27691
    label: GT1a
  - id: CHEBI:28058
    label: GT1b
  - id: CHEBI:27515
    label: GQ1b
  - id: CHEBI:8382
    label: prednisone
  - id: CHEBI:2948
    label: azathioprine
  - id: CHEBI:4031
    label: cyclosporine
  - id: HP:0410281
    label: Indigestion
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0025502
    label: overweight
  - id: HP:0001513
    label: obesity
  - id: MONDO:0018353
    label: Refractory Celiac Disease (RCD)
  - id: MAXO:0000757
    label: Infusions
  - id: HP:0000739
    label: anxiety
  - id: HP:0002315
    label: Headache
  - id: HP:0100785
    label: Insomnia
  - id: HP:0004396
    label: Loss of appetite
  - id: CHEBI:63623
    label: Dimercaptosuccinic acid
  - id: CHEBI:25140
    label: Maltodextrin
  - id: CHEBI:27300
    label: Vitamin D
  - id: CHEBI:22984
    label: Calcium
  - id: MAXO:0001610
    label: Transcranial Magnetic Stimulation
  - id: CHEBI:29987
    label: glutamate
  - id: HP:0000988
    label: Rash
  - id: MONDO:0009032
    label: Celiac disease (CeD)
  - id: HP:0002013
    label: vomiting
  - id: HP:0002024
    label: malabsorption
  - id: CHEBI:48416
    label: Olmesartan
  - id: CHEBI:35457
    label: ACE inhibitors (ACEIs)
  - id: MAXO:0000824
    label: Hemoglobin measurement
  - id: HP:0002102
    label: pleurisy
  - id: HP:0001701
    label: pericarditis
  - id: HP:0001541
    label: ascites
  - id: HP:0000238
    label: hydrocephalus
  - id: HP:0002018
    label: Nausea
  - id: CHEBI:74859
    label: anti-tissue transglutaminase IgA (TG)
  - id: CHEBI:6541
    label: Losartan
  - id: MAXO:0035049
    label: Endoscopic retrograde cholangiopancreatography
  - id: HP:0005214
    label: intestinal obstruction
  - id: MAXO:0001175
    label: Liver transplantation
  - id: MAXO:0000503
    label: Mechanical ventilation
  - id: MAXO:0000602
    label: Hemodialysis
  - id: HP:0031258
    label: Delirium
  - id: HP:0001250
    label: Seizures
  - id: HP:0001259
    label: Coma
  - id: HP:0007185
    label: Loss of consciousness
  - id: CHEBI:49575
    label: Diazepam
  - id: HP:0100753
    label: Schizophrenia
  - id: MAXO:0001193
    label: Upper gastrointestinal endoscopy
  - id: MAXO:0000108
    label: Iron supplementations
  - id: MAXO:0001129
    label: Vitamin supplementations
  - id: HP:0001891
    label: Iron deficiency anemia
  - id: HP:0001889
    label: Megaloblastic anemia
  - id: HP:0002028
    label: Chronic diarrhea
  - id: CHEBI:18248
    label: Iron
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0005344
    label: Hepatitis B
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assays (ELISA)
  - id: CHEBI:80165
    label: GIPs
  - id: MONDO:0023605
    label: Lane-Hamilton syndrome (LHS)
  - id: HP:4000055
    label: Intestinal inflammation
  - id: CHEBI:16301
    label: Nitrite
  - id: CHEBI:17632
    label: Nitrate
  - id: HP:0011793
    label: malignancy
  - id: CHEBI:50249
    label: anticoagulants
  - id: HP:0002639
    label: Budd-Chiari syndrome
  - id: MONDO:0010947
    label: Budd-Chiari syndrome
  - id: HP:0100512
    label: Vitamin D deficiency
  - id: CHEBI:82594
    label: Ferritin
  - id: CHEBI:27363
    label: Zinc
  - id: HP:0001824
    label: weight loss
  - id: CHEBI:8499
    label: propranolol
  - id: CHEBI:46195
    label: acetaminophen
  - id: CHEBI:258351
    label: practolol
  - id: CHEBI:18332
    label: levothyroxine
  - id: CHEBI:33281
    label: antibiotics
  - id: MONDO:0010138
    label: Gluten-related disorders (GRD)
  - id: CHEBI:75769
    label: B vitamins
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0001945
    label: Fever
  - id: HP:0012735
    label: Cough
  - id: HP:0033050
    label: Sore throat
  - id: HP:0002094
    label: Dyspnea
  - id: HP:0001953
    label: Diabetic ketoacidosis
  - id: HP:0000407
    label: Sensorineural hearing loss
  - id: HP:0002870
    label: Obstructive sleep apnea
  - id: HP:0000421
    label: Epistaxis
  - id: HP:0002321
    label: Vertigo
  - id: HP:0000639
    label: Nystagmus
  - id: HP:0000938
    label: osteopenia
  - id: HP:0002960
    label: autoimmune diseases
  - id: MONDO:0008558
    label: primary immune thrombocytopenia (ITP)
  - id: CHEBI:35472
    label: anti-inflammatory drugs
  - id: HP:0001394
    label: Cirrhosis
  - id: HP:0012538
    label: gluten sensitivity
  - id: MONDO:0005155
    label: Cirrhosis
  - id: HP:0004395
    label: Malnutrition
  - id: HP:0007378
    label: Gastrointestinal tumors
  - id: HP:0004322
    label: Short stature
  - id: MONDO:0005011
    label: Crohn's disease
  - id: HP:0006297
    label: enamel hypoplasia
  - id: HP:0200035
    label: plaque
  - id: CHEBI:17051
    label: fluoride
  - id: MAXO:0000110
    label: vitamin D supplementation
  - id: MAXO:0001139
    label: calcium supplementation
  - id: HP:0025406
    label: weakness
  - id: HP:0020110
    label: fractures
  - id: HP:0012531
    label: Pain
  - id: MONDO:0004790
    label: Hepatic Steatosis (nonalcoholic fatty liver disease, NAFLD)
  - id: HP:0002910
    label: elevated transaminases
  - id: HP:0001392
    label: liver disorders
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0007179
    label: Autoimmunity
  - id: MONDO:0010602
    label: Hemophilia A
  - id: CHEBI:145810
    label: Insulin
  - id: CHEBI:75431
    label: Ghrelin
  - id: CHEBI:81572
    label: Adiponectin
  - id: CHEBI:81571
    label: Leptin
  - id: CHEBI:27470
    label: folate
  - id: CHEBI:17230
    label: homocysteine
  - id: MONDO:0003240
    label: Thyroid Disease
  - id: MONDO:0019473
    label: Enteropathy-associated T-cell lymphoma (EATL)
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0002239
    label: Gastrointestinal haemorrhages
  - id: CHEBI:28748
    label: Doxorubicin
  - id: CHEBI:4027
    label: Cyclophosphamide
  - id: CHEBI:28445
    label: Vincristine
  - id: HP:0000969
    label: Edema
  - id: HP:0003073
    label: Hypoalbuminemia
  - id: HP:0001254
    label: Lethargy
  - id: HP:0002615
    label: Hypotension
  - id: HP:0001510
    label: Growth delay
  - id: HP:0002194
    label: Delayed motor skills
  - id: HP:0003256
    label: Coagulopathy
  - id: HP:0001942
    label: Metabolic acidosis
  - id: HP:0001873
    label: Thrombocytopenia
  - id: HP:0001508
    label: failure to thrive
  - id: HP:0012378
    label: fatigue
  - id: CHEBI:71200
    label: Tofacitinib
  - id: CHEBI:66919
    label: Ruxolitinib
  - id: CHEBI:15443
    label: Inulin
  - id: CHEBI:35143
    label: Hemoglobin
  - id: CHEBI:231491
    label: C-reactive protein (CRP)
  - id: MONDO:0007699
    label: Hashimoto's Thyroiditis
  - id: HP:0034588
    label: crypt hyperplasia
  - id: MAXO:0001298
    label: therapies
  - id: MONDO:0018895
    label: Plummer-Vinson syndrome
  - id: HP:0002015
    label: Dysphagia
  - id: HP:0030318
    label: Angular cheilitis
  - id: HP:0010298
    label: Atrophic glossitis
  - id: MAXO:0000144
    label: histological examination
  - id: CHEBI:16664
    label: albendazole
  - id: HP:0012414
    label: duodenal atrophy
  - id: MAXO:0000623
    label: dietary counseling
  - id: MONDO:0005277
    label: Migraine
  - id: HP:0002076
    label: migraine
  - id: HP:0001249
    label: Mental retardation
  - id: HP:0001251
    label: Ataxia
  - id: MAXO:0000778
    label: urine analysis using lateral flow test (LFT) and G12 monoclonal antibody
  - id: MONDO:0000816
    label: Metabolic Syndrome
  - id: HP:0000855
    label: Insulin resistance
  - id: HP:0012743
    label: Abdominal obesity
  - id: HP:0011123
    label: Dermatitis
  - id: HP:0004789
    label: Lactose intolerance
  - id: CHEBI:190522
    label: gliadin
